DiscoverEpidemics and VaccinesViral vectored vaccine development
Viral vectored vaccine development

Viral vectored vaccine development

Update: 2012-11-14
Share

Description

Professor Sarah Gilbert talks about her work on viral vectored vaccines. Viral vectored vaccines combine a safe virus with a disease protein to protect against specific diseases. These vaccines have the potential to drastically improve public health. Professor Sarah Gilbert has been making and testing vaccines designed to induce T cell responses for ten years, chiefly using antigens from malaria and influenza. Based at the Jenner Institute, several of the vaccines developed in Professor Gilbert's laboratory have progressed into clinical trials. Creative Commons Attribution-Non-Commercial-Share Alike 2.0 UK: England & Wales; http://creativecommons.org/licenses/by-nc-sa/2.0/uk/
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Viral vectored vaccine development

Viral vectored vaccine development

Sarah Gilbert